Huntington's disease (HD) (The Huntington's Disease Collaborative Research Group, 1993) , spinocerebellar ataxia types 1, 2, 3, 6, 7, 12, and 17 (SCA1, 2, 3, 6, 7, 12, 17 ) (Orr et al. 1993; Kawaguchi et al. 1994; Pulst et al. 1996; Sanpei et al. 1996; Imbert et al. 1996; Zhuchenko et al. 1997; David et al. 1997; Holmes et al. 1999; Nakamura et al. 2001) , and dentatorubral and pallidoluysian atrophy (DRPLA) (Koide et al. 1994; Nagafuchi et al. 1994) . With the exception of SCA12, each is caused by a CAG repeat expansion within an open reading frame, resulting in an expanded glutamine repeat (Zoghbi and Orr 2000) . CAG repeat expansion and concomitant polyglutamine expression have been linked to a variety of neurodegenerative conditions. Common features of these disorders include autosomal dominant inheritance (except for SBMA), varying clinical presentation correlated with the length of the mutated trinucleotide repeats, and phenotypic anticipation caused by the intergenerational instability of the trinucleotide repeats.
Several reports, however, have indicated that approximately one quarter to one third of Japanese patients with autosomal dominant spinocerebellar ataxia have no mutational expansion of the known CAG repeats (Matsuyama et al. 1997; Takano et al. 1998; Watanabe et al. 1998; Sasaki et al. 2000) . This raises the possibility that novel trinucleotide expansion could be responsible for autosomal dominant spinocerebellar ataxias and other inherited neurodegenerative diseases for which gene mutations remain unidentified. To identify candidate genes for these diseases, we screened a human brain cDNA library for cDNA clones containing CAG repeat sequences and examined the size of the repeats in Japanese patients with autosomal dominant neurodegenerative diseases.
Introduction
Recent advances in molecular genetics have revealed a novel class of genetic mutations, called trinucleotide repeat expansion, which are commonly observed in at least 15 inherited neuromuscular disorders . Among these, expanded CAG repeats are associated with inherited neurodegenerative diseases, including spinal and bulbar muscular atrophy (SBMA) (La Spada et al. 1991) , 1,000,000 plaques were screened. Filters were hybridized at 50°C in 0.9 M sodium chloride and 90 mM sodium citrate (6 ϫ SSC) and washed at 65°C in 6 ϫ SSC/0.1% sodium dodecyl sulfate. After plaque purification, plasmids were excised using an in vivo excision procedure. Inserts were sequenced using the PRISM ReadyReaction BigDye Terminator cycle sequencing kit (Applied Biosystems, Foster City, CA, USA) on an ABI Model 377 DNA sequencer. Genes were assigned to a chromosome or specific locus using the following databases: NCBI LocusLink (http://www.ncbi.nlm.nih.gov/LocusLink); GenomeNet Homo sapiens Genes (http://www.genome.ad.jp/dbgetbin/get_htext?H.sapiens); HGREP (http://hgrep.ims.utokyo.ac.jp/); and Celera (http://publication.celera.com/).
Patients, PCR, and polymorphism analysis
Two hundred and seventy-eight genetically undiagnosed patients whose clinical phenotypes included hereditary spinocerebellar degeneration, sporadic spinocerebellar degeneration, multiple system atrophy, familial dementia, dystonia/chorea, or spastic paraplegia were selected from the DNA collection maintained by the Department of Neurology, University of Tokyo. Polymerase chain reaction (PCR) was performed using primers flanking the CAG regions to analyze the length of the CAG repeats. The variability of repeat length was determined by size separation of the radiolabeled PCR products on 6% denaturing polyacrylamide gels.
Results
Through a screen for CAG repeat-containing cDNAs, we isolated 62 clones and identified 16 genes containing CAG repeats, as shown in Table 1 . Fourteen of the repeats occur in open reading frames, with eight of the repeats coding for polyglutamine, three for polyalanine, and three for polyserine. The remaining two repeats occur in noncoding regions. Among these clones were the androgen receptor (AR) gene and the TATA-binding protein (TBP) gene, which are known to be responsible for SBMA (La Spada et al. 1991 ) and SCA17 (Nakamura et al. 2001) . For the remaining CAG repeat-containing genes, we examined genomic DNA from 278 patients with neurodegenerative diseases to identify potential CAG repeat expansion. Of these 14 genes, we found polymorphisms in CAG repeat length only in the ribosomal protein L14 (RPL14) gene , the EST corresponding to accession no. U80740 (Margolis et al. 1997) , and the dachsund (DACH) gene, which encodes a putative transcription factor (Kozmik et al. 1999) (Table 2 ). Except for the three cases, there were no sequence polymorphisms in the isolated clones. The CAG repeat length polymorphisms in the RPL14 gene and the EST U80740 have been reported previously (Aoki et al. 1996; Margolis et al. 1997) , and the distribution of CAG repeat lengths in our study was within the range of those previously reported. We focused on characterizing those in the DACH gene, comparing the allele frequency between patients and controls. The frequency of TBP, TATA-binding protein; AR, androgen receptor; THRAP, thyroid hormone receptor-associated protein; SATB1, special AT-rich sequencebinding protein 1; TNRC9, trinucleotide repeat containing 9; RPL14, ribosomal protein L14; SRP14, signal recognition particle 14 kD; MLLT3, myeloid/lymphoid or mixed-lineage leukemia human homolog of trithorax (Drosophila); DACH, human homolog of dachshund (Drosophila); BNAP, Brain nucleotide assembly protein; CGI-19, comparative gene identification-19 a Polymorphic allele the dachshund serine 26 allele was 0.94% in our neurodegenerative disease patients (n ϭ 212) and 0.22% in controls (n ϭ 1348), giving no significant differences ( 2 ϭ 1.54, P ϭ 0.214). Therefore, we were unable to detect abnormal CAG repeat expansion within these 16 genes in our series of Japanese patients.
Discussion
We report here the isolation of 16 genes containing CAG repeats through the screening of a human fetal brain cDNA library. Most of the repeats were located within open reading frames, although two were found in noncoding regions. Although most CAG repeats responsible for inherited neurodegenerative diseases occur within the coding region and encode polyglutamine, CAG repeats in noncoding regions also can cause neurodegenerative diseases, including SCA8 and SCA12. In addition, abnormal expansion of GCG repeats encoding polyalanine is known to be responsible for oculopharyngeal muscular dystrophy and synpolyductyly (Muragaki et al. 1996; Brais et al. 1998 ). The CAG repeat-containing genes identified in this study may thus be candidate genes for neurodegenerative diseases without known mutations.
For autosomal dominant spinocerebellar ataxias, several reports have shown considerable differences in mutation frequency among different ethnic origins (Leggo et al. 1997; Moseley et al. 1998; Takano et al. 1998; Tang et al. 2000) . For example, although the SCA3 mutation is the most frequent in the majority of ethnic origins studied, DRPLA and SCA6 are much more rare in Caucasians than in Japanese individuals (Takano et al. 1998) . It has also been reported that the prevalence of Huntington's disease is markedly different between the Japanese and Caucasian populations (Kremer et al. 1994) . Although the genes identified in this study showed no mutational expansion of CAG repeats within our sample of Japanese patients, they remain potential candidate genes for neurodegenerative diseases in other ethnic groups. Aoki et al. 1996. Caucasians (b) and African-Americans (c)
